Signal Transduct Target Ther February 2023 PMID 36797239

Targeting epigenetic regulators to overcome drug resistance in cancers.

Nan Wang, Ting Ma, Bin Yu

Download social card

Mentions

Peak: 5 in Feb 2023

across 2 sources since Feb 2023

Extended reach

23,327

potential audience

Total likes

Video views

Mentions per month

Feb 2023 – Jun 2023

Where it's discussed

X / Twitter5 posts
YouTube1 videos

AI synopsis

What people are saying

The discussions highlight the importance of targeting epigenetic regulators like histone demethylases in cancer therapy, with phrases such as 'just out' and 'targeting' reflecting genuine interest. The tone indicates recognition of the research's potential, although most comments function as announcements with limited detailed critique or deep analysis.

AgreementModerate agreement

Most discussions express approval or positive acknowledgment of the publication, indicating general agreement on its significance.

InterestHigh interest

The posts demonstrate high interest, often emphasizing the importance and relevance of the research for cancer treatment.

EngagementModerate engagement

While some posts mainly announce the article’s publication, others show moderate engagement by discussing its focus and potential impact.

ImpactModerate impact

There is a shared perception that this research could influence future approaches in overcoming drug resistance, suggesting a moderate to high perceived impact.

Abstract in brief

Epigenetic regulation plays a key role in cancer drug resistance, which leads to tumor recurrence and poor patient outcomes.
The review focuses on how histone demethylases, as crucial factors in epigenetic modifications, influence tumor resistance and discusses strategies such as small-molecule inhibitors and siRNA to target these enzymes.
Overall, targeting epigenetic regulators, especially histone demethylases, offers a promising approach to overcome drug resistance in cancer treatment.]

Read the full abstract

All mentions

Targeting Epigenetic Regulators to Overcome Cancer Drug Resistance

Epigenetic regulation plays a key role in cancer drug resistance, leading to tumor recurrence and poor outcomes. This video discusses targeting histone demethylases with small-molecule inhibitors and siRNA as promising…

Medicine RTCL TV · Jun 25, 2023 39 views

Vince Beltran, Ph.D.

@levin_beltran · X

RT @drugdiscpapers: Targeting epigenetic regulators to overcome drug resistance in cancers https://t.co/ib8T0TJCP2

Feb 22, 2023 · 1 share · 11,768 followers View post →

drugdiscoverypapers

@drugdiscpapers · X

Targeting epigenetic regulators to overcome drug resistance in cancers https://t.co/ib8T0TJCP2

Feb 22, 2023 · 1 like · 1 share · 62 followers View post →

Denis Odinokov

@denis_odinokov · X

RT @BinYu_ZZU: Our latest review article on targeting epigenetic regulators to overcome drug resistance in cancers is just out in Signal Tr…

Feb 19, 2023 · 1 share · 40 followers View post →

htw

@heniek_htw · X

Targeting #epigenetic regulators to overcome drug resistance in #Cancers https://t.co/sdMlS9mTtk https://t.co/mAfkHBOAnm

Feb 18, 2023 · 4 likes · 11,265 followers View post →

Bin Yu, PhD

@BinYu_ZZU · X

Our latest review article on targeting epigenetic regulators to overcome drug resistance in cancers is just out in Signal Transduction and Targeted Therapy. https://t.co/Bp15UyHtne

Feb 18, 2023 · 7 likes · 1 share · 145 followers View post →